Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Terzah M. Horton, MD, PhD
Texas Children's Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Stanford Cancer Center at Stanford University Medical Center
Stanford, California, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Fairview University Medical Center - University Campus
Minneapolis, Minnesota, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Herbert Irving Comprehensive Cancer Center at Columbia University
New York, New York, United States
- Suny Upstate Medical University Hospital
Syracuse, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Dallas, Texas, United States
- Baylor University Medical Center - Houston
Houston, Texas, United States
- Children'S Hospital and Regional Medical Center - Seattle
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2004
- Primary completion
- 30 Sept 2004
- Completion
- 30 Jun 2008
- Last update posted
- 20 Feb 2014
- Registered enrollment
- 16
- Registry id
- NCT00083070
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.